Selio Medical

Selio Medical is a Dublin-based medical device company focused on innovative biomaterial technology to enhance outcomes for lung cancer patients during lung biopsy procedures. Co-founded by Colm McGarvey and Dr. Garrett Ryan, the company emerged from research at prominent Irish institutions and has received support from organizations like Enterprise Ireland and the European Innovation Council. Selio Medical employs between 11 and 50 people. The company's flagship product, the Selio Sealant System, is a single-use medical device that temporarily seals the needle access route into the lung before a biopsy. This biodegradable hydrogel sealant creates an airtight seal, significantly reducing the risk of pneumothorax, a common complication in lung biopsy patients. By preventing air leaks, the device allows patients to return home the same day, improving their quality of care and reducing healthcare costs. Selio Medical's product is designed for interventional radiologists and has received FDA 510(k) clearance, supporting its integration into current clinical practices.

• Employees 9
• Founded 2017